Diabetic Retinopathy Treatment Market

fmiresearch

Diabetes is a chronic disorder associated with defects in the secretion of insulin from the pancreas or hyperglycemia linked to insulin resistance which ultimately leads to long term multi-organ complications of eye, kidneys, nerves, blood vessels and heart. The most common and severe sight threatening complication of diabetes is Diabetic Retinopathy (DR) with some form of DR present in around 25-33% diabetic persons at any time.

Diabetic Retinopathy

Treatment Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

2016

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com


Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas

Customized

Research

Syndicated

Research

Investment

Research

Social Media

Research

Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com


Report Description

Diabetes is a chronic disorder associated with defects in the secretion of insulin from the

pancreas or hyperglycemia linked to insulin resistance which ultimately leads to long

term multi-organ complications of eye, kidneys, nerves, blood vessels and heart. The

most common and severe sight threatening complication of diabetes is Diabetic

Retinopathy (DR) with some form of DR present in around 25-33% diabetic persons at

any time. It leads to damaging of the blood vessels present in the retina of the eye. As

per WHO estimates, DR contributes around 4.8% of blindness globally. In the US, it is the

leading cause of vision loss and new-onset of blindness in working adults. At present

diabetes effects 336 million people worldwide which are projected to increase by 54% in

2030 and more than 75% among these diabetic for more than 20 years are likely to have

some form of diabetic retinopathy.

Diabetic Retinopathy Treatment Market: Drivers and Restraints

Diabetic Retinopathy affects both type 1 and type 2 diabetic patients and with prolific

increase in patient pool for both the indication, the market for diabetic retinopathy holds

great hopes. As per WHO, 41 percent of the population with diabetes are elderly hence

the growing market for diabetic retinopathy can be attributed to expanding geriatric

population size. In addition to this, up-gradation of healthcare infrastructure along with

the growing demand for early detection systems are some of the high impact rendering

drivers for the DR market. Also the clinical pipeline for DR seems full of promises with lots

of drug under umbrella specifically targeting diabetic retinopathy among the diabetic

patients.


Report Description

However, a dearth of skilled ophthalmologist combined with poor primary infrastructure

and lack of insurance facilities are restraining the growth of global diabetic retinopathy

market.

Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1322

Diabetic Retinopathy Treatment Market: Segmentation

Diabetic Retinopathy Treatment market is classified on the basis of Indication, Treatment

type, end users and geography.

Based on indication, the global diabetic retinopathy marketcan be segmented as follows:

• Non-Proliferative Diabetic Retinopathy (NPDR)

• Mild

• Moderate

• Severe

• Proliferative Diabetic Retinopathy (PDR)

Based on Treatment type, the global diabetic retinopathy marketcan be segmented as

follows:

• Anti-Vascular Endothelial Growth Factor (VEGF) drug


Report Description

• Intraocular Steroid Injection

• Laser Surgery

• Vitrectomy

Based on end-user, the global diabetic retinopathy marketcan be segmented as follows:

• Hospitals

• Ophthalmic Clinics

• Ambulatory Surgical Centers

Diabetic Retinopathy Treatment Market: Overview

According to WHO estimates, in 2012, 347 million people were suffering from diabetes

globally, of which 11% had diabetic retinopathy. This gigantic population size is expected

to increase further with a huge CAGR in coming years. Owing to improved infrastructure

and awareness among the people especially of emerging markets like China, India and

Brazil, there is strong emphasis on the quality of life (QALY) for diabetic patients

demanding early detection and treatment of chronic conditions such as Diabetic

Retinopathy, the market seems to be agile and open.

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1322

Diabetic Retinopathy triples the chances of vision impairment and is linked to five-fold

risk of blindness.


Report Description

However, people suffering from DR can be treated most commonly with laser to prevent

visual impairment and blindness. However, there is a need for the development of lowcost,

portable and easy to operate laser devices. Thus paying way to address various

unmet need in the diabetic retinopathy market which is expected to grow at great pace

in the coming 20 years.

Diabetic Retinopathy Treatment Market: Region-wise Outlook

Region wise, the global diabetic retinopathy treatment marketis classified into regions

namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific,

Japan, Middle East and Africa.Among all the geographies, North America dominated the

market followed by Europe. The factors attributable for North America is having high

obesity rates while Europe has large population of baby boomers. Asia is expected to

show the booming growth in next five years. Within the Asian region, western pacific

region account for greater share of blindness due to DR as compared to South-East Asia.

The major factor contributing to the rising share of Diabetic Retinopathy among the rising

economies are large pool of patients and rising support and funding provided by the

government. Under Rest of the World section Brazil is the largest market of diabetic

retinopathy.

Browse full report: http://www.futuremarketinsights.com/reports/diabetic-retinopathytreatment-market


Report Description

Diabetic Retinopathy Treatment Market: Key Players

The global Diabetic Retinopathy treatment market is dominated by Bayer AG, Pfizer Inc.,

Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant

Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc., Ampio

Pharmaceuticals Inc., etc. Strategic acquisitions, geographic expansion, agreements, new

product launches and collaborations are the major adopted strategies by most key

players to achieve growth in the global Diabetic Retinopathy.


Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

sales@futuremarketinsights.com

For other queries contact: Mr. Sudip Saha

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines